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Cholesterol regulates activation of sterol regulatory element-binding protein (SREBP) through
a classic feedback loop. Walker et al. (2011) extend the regulatory inputs governing SREBP activity
to include an independent loop modulated by phosphatidylcholine (PC) and cellular methylation
capacity. These findings suggest a link between lipid synthesis and cellular pathways involved in
methylation.Sterol regulatory element-binding pro-
teins (SREBPs) are a family of transcrip-
tion factors that regulate lipidmetabolism.
Mammals have three SREBP isoforms,
SREBP-1a, SREBP-1c, and SREBP-2.
SREBP-1 controls lipogenic pathways,
whereas SREBP-2 is more famously
specific for cholesterol biosynthesis
(Horton et al., 2002). To date, control of
the transcriptional activity of these
SREBPs by cholesterol provides a classic
example of a complex regulatory feed-
back mechanism (Figure 1A). The speci-
ficity in the activation of the different
SREBP isoforms, however, has been
less well understood. Walker et al. now
provide new insight as they uncover an
unexpected mechanism for activating
SREBP-1, one that’s initiated by de-
creased cellular methylation capacity
(Walker et al., 2011), which ties SREBP-1
function to PC levels and the cellular pool
of methyl group donors.
SREBP-1 and -2 are synthesized as
precursors that reside in the endoplasmic
reticulum (ER) membrane, where they
interact with SREBP cleavage-activating
protein (SCAP) (Figure 1A). When choles-
terol levels are low, SCAP mediates stan-
dard ER toGolgi transport of the complex,
which is necessary for activation of
SREBP by two proteases (S1P and S2P)
residing in the Golgi. The proteases
sequentially cleave SREBP to release
the N-terminal nuclear fragment, desig-
nated as nSREBP, which functions as
a transcription factor. SCAP senses levels
of cholesterol in the ER membrane, and
elevated levels of sterols trigger a confor-mational change in SCAP, causing an
interaction with another ER membrane
protein, Insig, leading to ER retention of
SREBP (Goldstein et al., 2006). As
nSREBP-2 mainly activates genes
involved in cholesterol biosynthesis, the
cholesterol-based regulation is supposed
to be relatively specific for SREBP-2.
Thus, elevated sterols reduce the levels
of nSREBP-2 in the nucleus and dampen
transcriptional output.
By contrast, SREBP-1 feeds into lipid
synthesis, where it’s known that insulin-
dependent activation of lipogenesis is
achieved by an increased accumulation
of nSREBP-1c. Insulin acts both to in-
crease SREBP-1c transcription (Li et al.,
2010) and to enhance cleavage of the
SREBP-1c precursor to generate the
nuclear fragment (Hegarty et al., 2005).
However, other regulatory inputs into
control of SREBP-1 were not known.
SREBP orthologs are conserved
among metazoans with one ortholog
in Caenorhabditis elegans, SBP-1. To
examine the regulatory controls on
SREBP-1, Walker et al. began with a
C. elegans model to find conserved
mechanisms for SREBP activation. Mi-
croarray analysis of worms depleted of
SBP-1 by RNAi confirmed that SBP-1
regulatesmany genes involved in lipogen-
esis. Unexpectedly, Walker et al. also
found enrichment of genes involved in
the folate cycle and homocysteinemetab-
olism (Walker et al., 2011). These path-
ways are also known as the one-carbon
cycle, as they are crucial for the synthesis
of S-adenosylmethionine, the methylCell 147, Ndonor in most methylation reactions
(Figure 1B). Decreasing methylation
capacity by depletion of sams-1, one of
the five genes encoding S-adenosylme-
thionine synthetase (SAMS), led to SBP-1
cleavage, a robust induction of SBP-1
target genes, and lipid accumulation,
whereas SBP-1 expression itself was not
changed. Worms with a hypomorphic
sbp-1 allele did not display this pheno-
type. These results point to an SBP-1-
mediated feedback loop that is activated
by low methylation capacity and stimu-
lates lipogenesis.
Metabolome analysis after sams-1
depletion revealed lower levels of phos-
phocholine and PC. This analysis indi-
cated that the methylation-dependent PC
biosynthesis pathway from phosphoetha-
nolamine (phosphatidylethanolamine in
mammals) was deficient (Figure 1B). Sup-
plementing the worms with excess
choline, which is necessary for methyla-
tion-independent PC synthesis, corrected
the lipogenic phenotype of sams-1 nema-
todes. Walker et al. concluded that
decreased PC levels were directly linked
to SBP-1 activation, a finding further
confirmed by RNAi knockdown of genes
in the PC biosynthesis pathway.
Turning to mammalian HepG2 cells,
knockdown of SAMS, as well as enzymes
in methylation-dependent and -indepen-
dent PC biosynthesis, resulted in nuclear
localization of SREBP-1, induction of
SREBP-1 target genes, and accumulation
of lipid droplets, in the absence of an
increase in SREBP-1 expression, mirror-
ing the results obtained in C. elegans.ovember 11, 2011 ª2011 Elsevier Inc. 719
Figure 1. The One-Carbon Cycle Modulates Lipogenesis via Phosphatidylcholine-Based
SREBP-1 Processing
(A) In classic cholesterol-based SREBP processing depicted for SREBP-2, when cholesterol is low,
SREBP-2 and SCAPmove from the ER to the Golgi, where proteases (S1P and S2P) process SREBP-2 to
release an N-terminal fragment, nSREBP-2. nSREBP-2 translocates to the nucleus where it functions as
a transcription factor, binding sterol response elements (SREs) in the promoters of genes involved in
cholesterol biosynthesis. In alternative PC-based SREBP-1 processing, decreased PC levels drive
retrogrademovement of S1P and S2P from the Golgi to the ER. In the ER, S1P and S2P release nSREBP-1
that, upon nuclear localization, induces lipid synthesis.
(B) Schematic representation of PC synthesis and its connection with one-carbon metabolism and lipid
synthesis. PC is generated by choline-dependent and -independent pathways. In the choline-independent
pathway, the one-carbon cycle is required alongside phosphatidylethanolamine synthesis to provide
methyl groups for phosphatidylethanolamine N-methyltransferase (PEMT). In the choline-dependent
pathway, dietary choline feeds into the cycle. Lipid synthesis intertwines with both pathways through the
production of diacylglycerol (DAG) that serves as the precursor for not only phospholipids but also
triglycerides (TGs). SREBP-1 regulates this lipogenic pathway. Other abbreviations used: CTa,
CTP:phosphocholine cytidylyltransferase a; SAH, S-adenosyl homocysteine; SAM, S-adenosyl methio-
nine; THF, tetrahydrofolate.Similarly, mice with a liver-specific
deletion of an enzyme in the choline-
dependent PC biosynthesis pathway,720 Cell 147, November 11, 2011 ª2011 ElseCTP:phosphocholine cytidylyltransferase
a, had decreased hepatic PC levels,
increased levels of nSREBP-1, as well asvier Inc.triglyceride accumulation. Thus, reduced
methylation capacity as well as reduced
PC levels increase SREBP-1-induced
lipogenesis.
Activation of SREBP-1 by PC depletion
occurred in the presence of cholesterol.
Moreover, PC depletion did not activate
SREBP-2. Together, these findings
suggest the existence of two specific
mechanisms for the activation of these
different SREBP isoforms.
To unravel the mechanism behind the
activation of SREBP-1 by PC depletion,
Walker et al. first used SCAP-deficient
cells. In these cells, PC depletion resulted
in robust activation of SREBP-1, showing
that the pathway is SCAP independent
and thus distinct from the classical
cholesterol-mediated pathway. Some-
what surprisingly, PC depletion led to
redistribution of Golgi proteins such as
the SREBP-activating proteases S1P
and S2P to the ER (Figure 1A). Although
the basis for this change in trafficking is
not fully explicated, Na¨a¨r and coworkers
speculate that changes in membrane lipid
composition occurring after PC depletion
affect membrane curvature, allowing for
this retrograde transport.
Although this work has revealed a novel
and alternative pathway for SREBP-1
activation, steered by low PC levels and
decreased cellular methylation capacity,
new questions arise. First, how is the
specificity of this pathway achieved? Re-
localization of S1P and S2P to the ER is
expected to activate SREBP-2 as well,
which had been demonstrated in
a previous study employing brefeldin A
(DeBose-Boyd et al., 1999). Walker et al.
found no evidence for SREBP-2 activation
after PC depletion, suggesting that
SREBP-2 may be protected from pro-
teolytic activation (Walker et al., 2011).
Along a similar line, does this novel
pathway activate SREBP-1a as well as
SREBP-1c, or is there specificity for one
of these isoforms? The regulatory model
implicates retrograde Golgi to ER trans-
port; however, the physiological condi-
tions that would deplete PC to initiate
this process remain to be elucidated. It
is conceivable that pathways that
consume considerable PC such as very
low-density lipoprotein secretion or bile
formation by hepatocytes or the synthesis
of surfactant by type II alveolar cells in the
lung will depend on such a mechanism
for SREBP-1 activation (Okazaki et al.,
2010; Xu et al., 2010).
It is remarkable that the connection
between SREBP and the folate cycle
and homocysteine metabolism was not
found sooner, given the previous microar-
ray analysis of different transgenic and
knockout mouse models in the SREBP
pathway (Horton et al., 2003). Using these
transgenic models, it will be interesting to
investigate how SREBP-1-mediated
changes in the one-carbon cycle impact
other methylation-dependent processes
such as DNA methylation (Blom and
Smulders, 2011). Given the known link
between metabolism and epigenetics,this may open the door on another very
interesting chapter in SREBP biology.
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The Parkinson’s disease proteins PINK1 and Parkin are proposed guardians of mitochondrial
fidelity, targeting damaged mitochondria for degradation by mitophagy. In this issue of Cell,
Wang et al. (2011) now show that PINK1 and Parkin also regulate mitochondrial trafficking and
quarantine damaged mitochondria by severing their connection to the microtubule network.To maintain the mitochondrial network
in good working order, mitochondria un-
dergo continuous cycles of fission and
fusion, promoting the redistribution of
refurbished contents throughout the
system. Sometimes, however, mitochon-
dria can become too badly damaged to
be rescued by this cycle and must be
culled from the network. We now under-
stand that these damaged organelles can
be recycled by a form of mitochondrial
autophagy known as mitophagy. Two
proteins known to be mutated in certain
forms of early onset Parkinson’s disease,
the E3 ubiquitin ligase Parkin and the
serine/threonine kinase PINK1, mediate
mitophagy following mitochondrial dam-
age and target specific substrates for pro-teasomal degradation (Deas et al., 2011;
Kawajiri et al., 2011). In this issue of Cell,
Wang et al. (2011) identify the mitochon-
drial outer-membrane protein Miro as
a substrate of PINK1 and show that it is
degraded through a Parkin-dependent
mechanism. Destruction of Miro unhooks
damaged mitochondria from the microtu-
bule network, preventing their transport
throughout the cell.
Previous studies have shown that the
PINK1/Parkin mitochondrial surveillance
pathway is activated when degradation
of PINK1 is inhibited, leading to an
increase in the abundance of PINK1 on
the mitochondrial outer membrane. This
increase results in the recruitment of Par-
kin to mitochondria by a kinase-depen-dent mechanism. Once present on mito-
chondria, Parkin ubiquitinates a subset
of protein targets, leading to their protea-
somal degradation and ultimately the
destruction of the entire damaged organ-
elle via mitophagy (Figure 1). As PINK1
and Parkin mutations are linked to neuro-
degeneration in Parkinson’s disease, the
study by Wang et al. adds the important
finding that Parkin is recruited to
damaged mitochondria not only in
cultured cell lines (Narendra et al., 2008),
but also in primary neurons.
Now, Miro has been identified as
a PINK1 substrate. Miro is a Rho-like
GTPase that plays an important role in
the movement of mitochondria within
cells. It is anchored by a single C-terminalovember 11, 2011 ª2011 Elsevier Inc. 721
